Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Medtronic
Moodys
McKinsey
Dow

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208079

See Plans and Pricing

« Back to Dashboard

NDA 208079 describes SERNIVO, which is a drug marketed by Encore Dermat and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug and one Paragraph IV challenge. Additional details are available on the SERNIVO profile page.

The generic ingredient in SERNIVO is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.
Summary for 208079
Tradename:SERNIVO
Applicant:Encore Dermat
Ingredient:betamethasone dipropionate
Patents:7
Formulation / Manufacturing:see details
Pharmacology for NDA: 208079
Suppliers and Packaging for NDA: 208079
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SERNIVO betamethasone dipropionate SPRAY;TOPICAL 208079 NDA Promius Pharma, LLC 67857-808 67857-808-04 1 BOTTLE in 1 CARTON (67857-808-04) > 120 g in 1 BOTTLE
Paragraph IV (Patent) Challenges for 208079
Tradename Dosage Ingredient NDA Submissiondate
SERNIVO SPRAY;TOPICAL betamethasone dipropionate 208079 2018-02-15

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SPRAY;TOPICALStrengthEQ 0.05% BASE/SPRAY
Approval Date:Feb 5, 2016TE:RLD:Yes
Regulatory Exclusivity Expiration:Feb 5, 2019
Regulatory Exclusivity Use:NEW DOSAGE FORM
Patent:  Start TrialPatent Expiration:Aug 31, 2030Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF PLAQUE PSORIASIS
Patent:  Start TrialPatent Expiration:Aug 31, 2030Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF PLAQUE PSORIASIS

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Colorcon
Medtronic
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.